| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 08/27/1997 | EP0791590A1 Benzothiophenes, and formulations and methods using same |
| 08/27/1997 | EP0790827A2 Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy |
| 08/27/1997 | EP0567469B1 14beta-H-, 14- AND 15-EN-11beta-ARYL-4-ESTRENES |
| 08/27/1997 | CN1158171A Current-to-pressure transducer with selectable, adjustable input filter |
| 08/27/1997 | CN1157719A Percutaneous applied medicine contained gestodene |
| 08/21/1997 | WO1997029767A1 Stabilised growth hormone formulation and method of preparation thereof |
| 08/21/1997 | WO1997029753A1 New associations of active principles containing clopidogrel and an antithrombotic agent |
| 08/20/1997 | EP0789764A1 A novel family of protease inhibitors, and other biologic active substances |
| 08/20/1997 | EP0789583A1 Methods and kits using macrophage stimulating protein |
| 08/20/1997 | CN1157566A Phosphonates and parathyroid hormone for osteoporosis |
| 08/20/1997 | CN1157565A Method for treatment of osteoporosis using bone active phosphonates and parathyroid hormone |
| 08/20/1997 | CA2197833A1 Pure somatostatin antagonist and methods of use thereof |
| 08/19/1997 | US5658922 4-aza-pregnane 5α-reductase isozyme 1 inhibitors |
| 08/19/1997 | US5658882 Methods of inducting formation of tendon and/or ligament tissue comprising administering BMP-12, BMP-13, and/or MP-52 |
| 08/14/1997 | WO1997029110A1 Thiophenopyrimidines |
| 08/14/1997 | CA2233307A1 Thiophenopyrimidines |
| 08/13/1997 | EP0788509A1 Therapeutic peptide derivatives |
| 08/13/1997 | EP0664811B1 Gestagenically active 19,11-bridged 4-estrenes |
| 08/13/1997 | CN1156998A Estra-1,3,5 (10)-triene derivatives, methods of preparing such compounds and pharmaceutical compositions containing them |
| 08/13/1997 | CN1156598A Medicine for treating thyreoidism |
| 08/12/1997 | US5656721 Having sugar moiety; prolonged duration of action |
| 08/12/1997 | US5656622 15,15-dialkyl-substituted derivatives of estradiol |
| 08/12/1997 | US5656598 Use of fibroblast growth factors to stimulate bone growth |
| 08/12/1997 | US5656481 Compositions and methods for the delivery of biologically active molecules using cells contained in biocompatible capsules |
| 08/07/1997 | WO1997028189A1 Methods for increasing endogenous levels of corticotropin-releasing factor |
| 08/07/1997 | WO1997028184A1 Method of treating beta-amyloid peptide associated conditions using trh |
| 08/07/1997 | WO1997028175A1 Thyroid sodium/iodide symporter and nucleic acid encoding same |
| 08/07/1997 | WO1997028116A1 Biphenyl compounds and use thereof as oestrogenic agents |
| 08/07/1997 | WO1997027869A1 Method for treatment of benign prostatic hypertrophy |
| 08/07/1997 | WO1997027846A1 Biphenyl compounds and use thereof as oestrogenic agents |
| 08/07/1997 | WO1997027845A1 Antiglucocorticoid drug |
| 08/07/1997 | CA2245145A1 Method of treating beta-amyloid peptide associated conditions using trh |
| 08/07/1997 | CA2244985A1 Antiglucocorticoid drug |
| 08/06/1997 | CN1035552C Branched alkylamino derivatives of thiazole, processes for preparing them and pharmaceutical compositions containing them |
| 08/05/1997 | US5653975 Implanting encapsulated cells capable of producing human growth factor or trophic factor for diffusion into the central nervous system; treatment of diabetes; anemia; hypoparathyroidism; parkinson's and alzheimer's disease |
| 07/31/1997 | WO1997027298A1 Biologically active and particularly peptide molecules having a potentiating effect on growth hormone biological activity |
| 07/31/1997 | WO1997027210A1 New 19-nor-pregnene derivatives |
| 07/30/1997 | EP0786011A1 A microbiological process for the preparation of 17beta-carboxy substituted 3-oxo-4-azasteroids and the use of such products as inhibitors of the enzyme 5alpha-reductase |
| 07/30/1997 | EP0785792A1 Treatment of ovarian estrogen dependent conditions |
| 07/30/1997 | EP0785784A1 4-heterocyclic piperidines promote release of growth hormone |
| 07/29/1997 | US5652259 Administering 3-aroyl-2-arylbenzo(b)thiophene derivatives |
| 07/29/1997 | US5652243 Modulating cellular response |
| 07/29/1997 | US5651973 Therapeutically effective topical application of ST1435 |
| 07/24/1997 | WO1997026328A1 Immunotherapy using cytotoxic t lymphocytes (ctl) |
| 07/24/1997 | WO1997026264A1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use |
| 07/24/1997 | WO1997021993A3 Nuclear receptor ligands and ligand binding domains |
| 07/24/1997 | WO1997007198A3 Dna sequences and secreted proteins encoded thereby |
| 07/24/1997 | CA2241565A1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use |
| 07/23/1997 | EP0785212A1 New 19-nor-pregnene derivatives |
| 07/23/1997 | EP0784677A1 Inhibitor of stem cell proliferation and uses thereof |
| 07/23/1997 | EP0649464B1 Transfection of vertebrate cells e.g. by homologous recombination |
| 07/23/1997 | EP0540717B1 UNSATURATED 17$g(b)-SUBSTITUTED 3-CARBOXY STEROIDS |
| 07/23/1997 | EP0451194B1 Recombinant dna molecules, hosts, processes and human somatomedin carrier protein-like polypeptides |
| 07/23/1997 | CN1155281A Noval pyrimidine derivatives and prepn. processes thereof |
| 07/23/1997 | CN1155276A Enzyme inhibitors |
| 07/22/1997 | US5650486 Monomeric insulin analog formulations |
| 07/17/1997 | WO1997025077A1 SKIN-ADHERING PHARMACEUTICAL PREPARATION, IN PARTICULAR TRANSDERMAL THERAPEUTIC SYSTEM FOR THE RELEASE OF 17-β-ESTRADIOL TO THE HUMAN ORGANISM |
| 07/17/1997 | WO1997017937A3 Gene-therapeutic nucleic acid construct, production of same and use of same in the treatment of heart disorders |
| 07/16/1997 | EP0783585A1 DEFFECTIVE RECOMBINANT ADENOVIRUSES WITH INACTIVATED IVa2 GENE |
| 07/16/1997 | EP0783521A1 Polypeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone |
| 07/16/1997 | EP0783314A2 Compositions containing at least one glucocorticoid in combination with a pulmonary surfactant for the treatment of irds and ards |
| 07/16/1997 | EP0783310A1 Novel hormonal medicaments and use thereof for correcting oestrogen deficiencies |
| 07/10/1997 | WO1997024445A1 Recombinant fusion proteins to growth hormone and serum albumin |
| 07/10/1997 | WO1997024440A1 Ob protein derivatives having prolonged half-life |
| 07/10/1997 | WO1997024369A1 Growth-hormone secretagogues |
| 07/10/1997 | WO1997024368A1 17beta-(2-oxo-tetrahydrofuran-4-yl)-thio-androstane derivatives (17beta-(gamma-butyric acid lactone)-thio derivatives) for the treatment of inflammation and pharmaceutical compositions and a process for the production thereof |
| 07/10/1997 | WO1997024119A1 Vitronectin receptor antagonists |
| 07/10/1997 | WO1997024116A2 METHODS OF TREATMENT WITH COMPOUNDS HAVING RARα RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY |
| 07/10/1997 | DE19600347A1 Hauthaftende pharmazeutische Zubereitung, insbesondere TTS zur Abgabe von 17-beta-Estradiol an den menschlichen Organismus Skin-adhesive pharmaceutical preparation, particularly TTS for the delivery of 17-beta-estradiol on the human organism |
| 07/10/1997 | CA2241758A1 Methods of treatment with compounds having rar.alpha. receptor specific or selective activity |
| 07/10/1997 | CA2241633A1 Vitronectin receptor antagonists |
| 07/10/1997 | CA2240292A1 Recombinant fusion proteins to growth hormone and serum albumin |
| 07/10/1997 | CA2238307A1 Ob protein derivatives having prolonged half-life |
| 07/09/1997 | EP0783001A1 Androstenones |
| 07/09/1997 | CN1153655A Chinese medicine prepn for balancing internal secretion |
| 07/08/1997 | US5646172 Method of inducing antiandrogenic activity using imidazolidines substituted with a heterocycle |
| 07/08/1997 | US5646152 Treating psychological disorders with corticotropin releasing factor antagonists |
| 07/08/1997 | US5646140 1,5-benzodiazepine derivatives having CCK antagonistic or agonistic activity |
| 07/08/1997 | US5646113 Treatment of partial growth hormone insensitivity syndrome |
| 07/03/1997 | WO1997023508A1 Compounds with growth hormone releasing properties |
| 07/03/1997 | WO1997023451A1 Tyrosin-derivate as alpha-v-integrin inhibitors |
| 07/03/1997 | WO1997016185A3 A pharmaceutical composition for the treatment of autoimmune diseases |
| 07/03/1997 | DE19548709A1 Tyrosinderivate Tyrosine derivatives |
| 07/03/1997 | CA2241149A1 Tyrosin-derivate as alpha-v-integrin inhibitors |
| 07/03/1997 | CA2239711A1 Compounds with growth hormone releasing properties |
| 07/02/1997 | CN1153044A Thyroid gland pill and producing process thereof |
| 07/01/1997 | US5643879 Oligopeptide enzyme inhibitors as hypotensive agents |
| 06/26/1997 | WO1997022620A1 Oligopeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone |
| 06/26/1997 | WO1997022618A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 06/26/1997 | CA2240489A1 Inhibitors of interleukin-1.beta. converting enzyme |
| 06/25/1997 | EP0780386A1 Matrix metalloprotease inhibitors |
| 06/25/1997 | EP0779813A1 Phosphonates and parathyroid hormone for osteoporosis |
| 06/25/1997 | EP0779812A1 Methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone |
| 06/25/1997 | CN1035256C Process for preparation of new polypetide compound |
| 06/19/1997 | WO1997021993A2 Nuclear receptor ligands and ligand binding domains |
| 06/19/1997 | WO1997021707A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | WO1997021704A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | WO1997021703A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | WO1997021435A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | WO1997016549A3 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands |